Abstract
Treatment of saccular aneurysms (SAs) depend on their morphology and location. Minimally invasive treatment options include coil embolization, flow diverter stents, stent-assisted coiling and liquid embolics. Many drawbacks are associated with these treatment options. To overcome these drawbacks, we developed and tested a novel biomaterial for the endovascular treatment of SAs in vitro, in cell culture, small and large animal models.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
